Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis
Public ClinicalTrials.gov record NCT04413942. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Multiple Intravenous Doses of FB825 in Adults With Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study aims to evaluate the efficacy, improvement from baseline in Eczema Area and Severity Index (EASI) score, of multiple intravenous (IV) doses of FB825 in subjects with atopic dermatitis
Study identification
- NCT ID
- NCT04413942
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 99 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 10, 2020 (Actual)
- Primary completion
- Dec 31, 2021 (Actual)
- Completion
- Jun 30, 2022 (Estimated)
- Last update posted
- Apr 4, 2022
2020 – 2022
United States locations
- U.S. sites
- 18
- U.S. states
- 5
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Zenith Research | Beverly Hills | California | 90212 | — |
| Encino Research Center | Encino | California | 91436 | — |
| Marvel Research 002, LLC | Huntington Beach | California | 92647 | — |
| Providence Clinical Research | North Hollywood | California | 91606 | — |
| ACRC Studies | San Diego | California | 92119 | — |
| Unison Clinical Trials | Sherman Oaks | California | 991403 | — |
| University Clinical Research - Deland, LLC | DeLand | Florida | 32720 | — |
| FXM Clinical Research Ft. Lauderdale, LLC. | Fort Lauderdale | Florida | 33308 | — |
| Sweet Hope Research Specialty | Hialeah | Florida | 33016 | — |
| Universal Axon - Homestead, LLC | Homestead | Florida | 33030 | — |
| FXM Clinical Research Miramar, LLC | Miramar | Florida | 33027 | — |
| FXM Clinical Research Miami, LLC | Miramar | Florida | 33175 | — |
| Moore Clinical Research | Tampa | Florida | 33609 | — |
| Avita Clinical Research (PCRS Network) | Tampa | Florida | 33613 | — |
| Oakland Hills Dermatology (PCRS Network) | Auburn Hills | Michigan | 48326 | — |
| Revival Research Institute, LLC | Troy | Michigan | 48084 | — |
| Paddington Testing Co, Inc | Philadelphia | Pennsylvania | 19103 | — |
| Clinical Research Partners | Richmond | Virginia | 23226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04413942, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 4, 2022 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04413942 live on ClinicalTrials.gov.